Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1995
10/04/1995EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/03/1995US5455338 Anticoagulants; protease inhibitors; thrombosis; surgery
10/03/1995US5455337 Treatment of asthma, helminth infections
10/03/1995US5455179 Quantitative analysis using polypeptide
10/03/1995US5455167 DNA construct encoding luxD protein in Brassica plant seed from bioluminescent bacterium; genetic engineering to produce C14:0 fatty acids
10/03/1995US5455164 Ruminant immortalized mammary epithelial cell lines
10/03/1995CA2054517C Recombinant adeno-associated virus vectors
10/03/1995CA2001395C Noningestible separation barrier with plugged pores
09/1995
09/28/1995WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
09/28/1995WO1995025808A1 Process for treating eucaryotic cells
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025798A1 Luciferases
09/28/1995WO1995025794A1 Anti-igf-i monoclonal antibody
09/28/1995WO1995025792A1 Neuron promoter and uses
09/28/1995WO1995025789A1 Highly efficient production and isolation of viral particles
09/28/1995WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
09/28/1995WO1995025787A1 Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025547A1 Devices and methods for implanting transduced cells
09/28/1995WO1995025535A1 Thyroxin-binding proteins
09/28/1995WO1995025531A1 Means for treating auto-immune diseases and method of treatment
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995WO1995025515A1 Inhibition of growth of cancer cells
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2186035A1 Thyroxin-binding proteins
09/28/1995CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995CA2185892A1 Means for treating auto-immune diseases and method of treatment
09/28/1995CA2185788A1 Neuron promoter and uses
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2183647A1 Process for treating eucaryotic cells
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0674007A1 Process for the preparation of pilocarpine
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673433A1 Hepatic model
09/27/1995EP0673431A1 Gene therapy for cystic fibrosis
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673420A1 Mammalian receptors for interleukin-10 (il-10)
09/27/1995EP0673419A1 Stably transfected cell lines expressing gaba-a receptors
09/27/1995EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
09/27/1995EP0673416A1 Oxalate decarboxylase
09/27/1995EP0673414A1 Method for enhancing the differentiation of plant cells in culture
09/27/1995EP0673387A1 Materials and methods for control of pests
09/27/1995EP0673382A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS
09/27/1995EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor
09/27/1995EP0673257A1 Low toxicity interleukin-2 analogues for use in immunotherapy
09/27/1995EP0673256A1 Suppression of myeloid cells
09/27/1995EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/1995EP0673243A1 Improving effectiveness of drugs.
09/27/1995EP0673238A1 Use of a simarouba extract to reduce patchy skin pigmentation
09/27/1995EP0673237A1 Use of a simaba extract to reduce patchy skin pigmentation.
09/27/1995EP0631618A4 Culturing of hematopoietic stem cells and their genetic engineering.
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/26/1995US5453491 Purified and comprising specified amino acid sequences; therapy for autoimmune disorders and eosinophilia
09/26/1995US5453368 Method of encapsulating biological substances in microspheres
09/26/1995US5453367 Transformation of hereditary material of plants
09/26/1995US5453366 Positioning donor nucleus adjacent to enucleated recipient oocyte; maintaining in medium to mature prior to fusion
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995US5453357 Fibroblast growth, leukemia inhibitory, membrane associated steel and soluble steel factors
09/22/1995CA2144898A1 Pilocarpin production process
09/21/1995WO1995025171A2 Dna sequences for matrix metalloproteases, their production and use
09/21/1995WO1995025164A1 Blood-borne mesenchymal cells
09/21/1995WO1995025114A1 Plant peptide transport gene
09/21/1995WO1995024969A1 Method and apparatus for semi-automated cell separation
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995024910A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995WO1995024873A1 Treated tissue for implantation and preparation methods
09/21/1995CA2207851A1 Plant peptide transport gene
09/21/1995CA2185539A1 Blood-borne mesenchymal cells
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/21/1995CA2184352A1 Immunotherapy of cancer with allogeneic lymphocytes
09/20/1995EP0672905A1 Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm
09/20/1995EP0672757A1 Functional assay method for the identification of thrombin receptor antagonists
09/20/1995EP0672685A2 Monoclonal antibody
09/20/1995EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0672162A1 ENHANCED PRODUCTION OF TAXOL AND TAXANES BY CELL CULTURES OF $i(TAXUS) SPECIES
09/20/1995EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination
09/20/1995EP0672159A1 In vivo homologous sequence targeting in eukaryotic cells
09/20/1995EP0672156A1 Bovine heat shock promoter and uses thereof
09/20/1995EP0672155A1 A method for obtaining a plant having altered floral morphology and a method for protecting plants against pest insects
09/20/1995EP0672146A1 Biocidal chitin binding proteins
09/20/1995EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM
09/20/1995EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
09/20/1995EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene
09/20/1995EP0672135A1 A cell expressing a glutamate receptor
09/20/1995EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
09/20/1995EP0672132A1 Receptor internalization signals
1 ... 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 ... 1827